Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.
scientific article published on 7 October 2016
Author/s
author: Yoon-Sim Yap, Gabe S Sonke, Fabrice André, Pierfranco Conte, Gabriel N Hortobagyi, Denise A Yardley, Joyce O'Shaughnessy, Eric Winer, Thomas Bachelot, Kimberly L Blackwell, Sibel Blau
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.